Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety. (Q44505285)

PubMed publication ID

12848808

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12848808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

M. Murat Samli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

author name string

Ersel Onrat

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

Cetin Dincel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

publication date

1 January 2003

1 reference

PubMed publication ID

12848808

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12848808%20AND%20SRC:MED&resulttype=core&format=json

Annals of Noninvasive Electrocardiology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

page(s)

14-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

QTc interval prolongation associated with citalopram overdose: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

Usefulness of QT dispersion immediately after exercise as an indicator of coronary stenosis independent of gender or exercise-induced ST-segment depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1542-474X.2003.08103.X

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

21 January 2018

1 reference

12 December 2020

Hypertension as a Risk for Erectile Dysfunction: Implications for Sildenafil Use.

1 reference

12 December 2020

Prolongation of the QT interval related to cisapride-diltiazem interaction.

1 reference

12 December 2020

Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias

1 reference

12 December 2020

QT dispersion: an indication of arrhythmia risk in patients with long QT intervals

1 reference

12 December 2020

Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells

1 reference

12 December 2020

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

12 December 2020

Erectile dysfunction and cardiovascular risk factors

1 reference

12 December 2020

QT dispersion in patients with end-stage renal failure and during hemodialysis.

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

12 December 2020

Dynamic changes of QT dispersion as a predictor of myocardial ischemia on exercise testing in patients with angina pectoris.

1 reference

12 December 2020

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

12 December 2020

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

12 December 2020

Dofetilide, a new class III antiarrhythmic agent

1 reference

12 December 2020

Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy

1 reference

12 December 2020

Medical treatment of erectile dysfunction

1 reference

12 December 2020

10.1046/J.1542-474X.2003.08103.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932612&resulttype=core&format=json

13 May 2020

PubMed publication ID

12848808

1 reference